Browse Category

Earnings Reports News 29 January 2026

Meta stock price jumps after earnings — but $135 billion AI capex is the new battleground

Meta stock price jumps after earnings — but $135 billion AI capex is the new battleground

Meta shares surged nearly 7% in early Frankfurt trading after the company reported a 24% jump in Q4 revenue to $59.89 billion and issued a strong Q1 forecast. Meta raised its 2026 capital expenditure guidance to $115–$135 billion, citing increased investment in AI infrastructure. Operating margin fell to 41% from 48% a year earlier. Investors weighed robust ad sales against rising costs and regulatory pressures.
British American Tobacco share price slips as buyback update lands, Feb 12 results in focus

British American Tobacco share price slips as buyback update lands, Feb 12 results in focus

BAT shares fell 0.3% to 4,321 pence in early London trading Thursday, underperforming the FTSE 100’s 0.6% gain. The company disclosed it bought 135,314 shares for cancellation on Jan. 28 as part of its buyback program. Investors are awaiting BAT’s full-year results, due Feb. 12. Imperial Brands shares also slipped 0.4%.
UOL Group stock price wobbles after JPMorgan upgrade pop; SGX:U14 traders eye Feb 26 results

UOL Group stock price wobbles after JPMorgan upgrade pop; SGX:U14 traders eye Feb 26 results

UOL Group shares fell 2 Singapore cents to S$10.81 by 2:09 p.m. Thursday, after swinging between S$11.34 and S$10.78 on volume of 1.21 million shares. The drop follows a sharp rally sparked by JPMorgan’s target price hike to S$12.05. UOL surged 8% Tuesday, then lost 3.1% Wednesday. Investors await full-year results due Feb. 26.
Keppel share price slips as Aster SAF plant study lands; next catalyst is Feb 5 results

Keppel share price slips as Aster SAF plant study lands; next catalyst is Feb 5 results

Keppel shares fell 0.27% to S$11.02 in afternoon trading after announcing a study with Aster for an ethanol-to-jet sustainable aviation fuel facility on Jurong Island. The project targets up to 100,000 tonnes annual output but awaits regulatory approval and a final investment decision. Investors are watching for capex details and the February 5 earnings report. Keppel said the plan won’t affect earnings this year.
OCBC stock price inches up as Citi-backed securities-lending launch keeps focus on Feb earnings

OCBC stock price inches up as Citi-backed securities-lending launch keeps focus on Feb earnings

OCBC shares rose 0.23% to S$21.34 in Singapore trading Thursday, with about 1.8 million shares changing hands. The bank launched a securities-lending program via Citi, aiming to expand to more clients by 2026. RHB raised its target price for OCBC to S$21.30, expecting single-digit earnings growth and a 60% dividend payout. OCBC will report full-year 2025 results on Feb. 25.
DBS stock touches S$60 as Feb 9 earnings loom and analysts split on value

DBS stock touches S$60 as Feb 9 earnings loom and analysts split on value

DBS shares touched S$60 before easing to S$59.87, up 0.6% in Thursday afternoon trading, with 2.44 million shares exchanged. The Monetary Authority of Singapore kept policy steady but raised its 2026 inflation forecast to 1%-2%. OCBC rose 0.3% while UOB slipped 0.3%. DBS reports results on Feb 9.
T-Mobile stock price rises as AT&T guidance lifts telecom mood; Verizon and TMUS earnings ahead

T-Mobile stock price rises as AT&T guidance lifts telecom mood; Verizon and TMUS earnings ahead

T-Mobile shares closed up 0.95% at $186.25 Wednesday, rebounding after Tuesday’s drop. AT&T jumped 4.65% after projecting annual profit above expectations and outlining fiber expansion plans. Verizon reports earnings Friday; T-Mobile will release results February 11. About 7.4 million T-Mobile shares changed hands.
Thermo Fisher (TMO) stock slides into earnings — here’s what Wall Street is watching

Thermo Fisher (TMO) stock slides into earnings — here’s what Wall Street is watching

Thermo Fisher shares fell 2.55% to $608.02 Wednesday, their second straight decline ahead of Thursday’s Q4 earnings call. Trading volume topped 2.3 million, above average, as investors weighed Danaher’s warning on weak academic research funding. The stock now sits 5.6% below its Jan. 22 high. Life-science tools stocks broadly declined during the session.
Elevance Health stock rebounds nearly 6% after earnings — here’s what matters before Thursday’s trade

Elevance Health stock rebounds nearly 6% after earnings — here’s what matters before Thursday’s trade

Elevance Health shares rose 5.9% to $341.85 Wednesday after plunging 14% the previous session. The insurer projected 2026 adjusted earnings of at least $25.50 per share, below analyst forecasts, and expects a small revenue decline. Fourth-quarter operating revenue rose 10% to $49.3 billion. Medicare Advantage payment changes and rising medical costs continue to drive volatility in managed-care stocks.
Uber stock drops 1.8% — Waabi robotaxi deal and Dutch driver ruling set up earnings test

Uber stock drops 1.8% — Waabi robotaxi deal and Dutch driver ruling set up earnings test

Uber shares fell 1.8% to $79.78 Wednesday, underperforming a flat S&P 500. A Dutch court ruled Uber drivers can be classified as self-employed, reversing a 2021 decision. Uber pledged up to $250 million to Waabi, aiming to deploy at least 25,000 robotaxis on its platform. Investors weighed regulatory and automation developments ahead of Uber’s Feb. 4 earnings report.
1 62 63 64 65 66 336

Stock Market Today

Carvana stock jumps 5% to $403.67 — here’s what CVNA traders are watching next

Carvana stock jumps 5% to $403.67 — here’s what CVNA traders are watching next

7 February 2026
Carvana shares rose 5.21% Friday to $403.67, rebounding after recent volatility sparked by a short-seller report from Gotham City Research. The company denied allegations of overstated earnings and undisclosed ties to DriveTime. Carvana will report Q4 and full-year 2025 results after markets close on Feb. 18. The January U.S. CPI report is scheduled for Feb. 13.
Confluent stock hugs IBM’s $31 bid — here’s what investors watch next week

Confluent stock hugs IBM’s $31 bid — here’s what investors watch next week

7 February 2026
Confluent shares closed at $30.57 Friday, 43 cents below IBM’s $31-per-share cash offer, ahead of key events next week. The company will report earnings Feb. 11 without a call or outlook, and shareholders vote on the merger Feb. 12. Confluent disclosed 17 demand letters and two lawsuits over proxy disclosures but denies wrongdoing. The IBM deal values Confluent at $11 billion.
Go toTop